• NADPH Oxidase-Derived ROS Activate LTCC in Neonatal Rat Arte

  2026-05-23

  This study reveals that NADPH oxidase-derived reactive oxygen species (ROS) drive arterial contraction in early postnatal rats by activating L-type voltage-gated Ca2+ channels (LTCC), rather than canonical Rho-kinase, PKC, or Src-kinase pathways. These results refine our understanding of age-dependent vascular tone control and suggest new directions for neonatal cardiovascular research.

• FBXO22 Degraders and 2-PCA Ligands: Expanding TPD Toolkits

  2026-05-22

  This study introduces potent chemical probes for targeted protein degradation (TPD) via FBXO22, a cancer-associated E3 ubiquitin ligase. By identifying AHPC(Me)-C6-NH2 as a selective FBXO22 degrader and 2-pyridinecarboxyaldehyde (2-PCA) as a novel recruitment ligand, the work broadens the strategies available for precise protein elimination in cellular models.

• Anlotinib in Intra-Abdominal Desmoplastic Small Round Cell T

  2026-05-22

  This article reviews a reference case study demonstrating anlotinib hydrochloride’s clinical impact in treating metastatic intra-abdominal desmoplastic small round cell tumor (IADSRCT)—a rare, aggressive malignancy with poor prognosis. The findings highlight the promise of multi-target tyrosine kinase inhibition in refractory sarcomas and outline implications for angiogenesis-focused cancer research.

• Glutamate Receptor Blockade Mitigates Soman-Induced Neurotox

  2026-05-21

  The referenced study demonstrates that dual-targeting glutamate receptor antagonism, specifically via IEM-1925, provides robust antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. These findings highlight the translational potential of selective AMPA receptor blockade for neuroprotection in organophosphorus nerve agent exposure.

• Anlotinib Hydrochloride: Potent VEGFR2 Inhibition in Tumor A

  2026-05-21

  The reference study establishes anlotinib hydrochloride as a highly potent and selective inhibitor of VEGFR2, demonstrating superior anti-angiogenic activity compared to existing small-molecule TKIs. Its capacity to block key steps in endothelial cell migration and neovascularization positions it as a valuable tool for preclinical cancer research and mechanistic angiogenesis studies.

• BAPTA-AM (SKU B4758): Precision Calcium Chelation for Reliab

  2026-05-20

  This article delivers scenario-driven, evidence-backed guidance on overcoming real laboratory challenges using BAPTA-AM (SKU B4758), a cell-permeable calcium chelator. Drawing from recent literature and validated protocols, it empowers biomedical researchers to achieve reproducible results in calcium signaling, apoptosis, and neuroprotection assays. The workflow-centric analysis highlights why BAPTA-AM is the trusted choice for sensitive intracellular calcium regulation.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L): Protocols & Pr

  2026-05-20

  The Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody from APExBIO sets a new benchmark for sensitive, reproducible signal amplification in immunoassays. This guide unpacks optimized workflows, troubleshooting strategies, and real-world applications in oncology research, directly referencing breakthrough studies on KRASG12V-driven colorectal cancer.

• Synergistic OXPHOS Disruption via LRPPRC Inhibition and Dasa

  2026-05-19

  This study demonstrates that combining LRPPRC inhibition with dasatinib leads to a synergistic and dual blockade of mitochondrial oxidative phosphorylation (OXPHOS) in cancer cells. By targeting both mitochondrial and nuclear-encoded OXPHOS genes, the approach enhances anti-tumor efficacy and provides a mechanistic rationale for tailored combination therapies in OXPHOS-dependent cancers.

• Clasto-Lactacystin β-lactone: Optimizing Proteasome Inhibiti

  2026-05-19

  Clasto-Lactacystin β-lactone enables precise, irreversible proteasome inhibition for dissecting the ubiquitin-proteasome pathway in cancer, neurodegeneration, and viral immunology. This guide delivers actionable protocols, troubleshooting strategies, and workflow innovations to maximize reproducibility and biological insight in your research.

• gamma-Glu-Cys Empowers Advanced Glutathione Metabolism Resea

  2026-05-18

  gamma-Glu-Cys (γ-Glu-Cys) from APExBIO streamlines high-fidelity glutathione metabolism research, kokumi peptide engineering, and plant stress studies. Discover protocol enhancements, comparative data, and troubleshooting strategies that maximize yield and reproducibility in diverse bioscience workflows.

• Arrb2 in Hepatocytes Alleviates Hepatic IRI via M2 Polarizat

  2026-05-18

  This study identifies hepatocyte-specific Arrb2 upregulation as a key driver of M2 macrophage polarization, thereby reducing hepatic ischemia–reperfusion injury (IRI) through enhanced production of the metabolite 6-ketoLCA. These findings clarify a novel hepatocyte-macrophage communication pathway, informing both mechanistic understanding and experimental strategies for hepatic IRI models.

• Applied Angiotensin II Workflows for Vascular Remodeling Res

  2026-05-17

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) enables precision modeling of vascular aging, hypertrophy, and inflammatory processes in both cell-based and animal systems. This guide delivers advanced protocols, troubleshooting strategies, and translates novel MFN2 pathway insights into actionable research enhancements—empowering scientists to maximize reproducibility and biological relevance with APExBIO's trusted reagent.

• NADPH Oxidase-Derived ROS Drive Early Postnatal Arterial Con

  2026-05-16

  This study reveals that in early postnatal rat arteries, reactive oxygen species (ROS) generated by NADPH oxidase promote vasoconstriction primarily via activation of L-type voltage-gated Ca2+ channels, rather than through canonical Rho-kinase, PKC, or Src-kinase pathways. These insights refine our understanding of redox-mediated vascular regulation in developmental physiology and inform targeted approaches for dissecting kinase signaling in vascular research.

• Vancomycin Hydrochloride in Antibiotic Resistance Assays

  2026-05-15

  Vancomycin hydrochloride is a foundational glycopeptide antibacterial agent for dissecting Gram-positive resistance mechanisms, screening novel antibiotics, and optimizing selective media. This article delivers actionable protocols, troubleshooting insights, and a reference-driven workflow upgrade for advanced resistance profiling.

• Bismuth Subsalicylate: Molecular Insights for GI Disorder Re

  2026-05-15

  Explore Bismuth Subsalicylate’s unique role in gastrointestinal disorder research through a molecular and assay-focused lens. This article reveals how 1,3,2λ2-benzodioxabismin-4-one advances research reproducibility and membrane biology beyond standard protocols.

8049 records 16/537 page Previous Next First page 上5页 1617181920 下5页 Last page